• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Azithromycin is not associated with increased cardiovascular death in low-risk groups

bys25qthea
May 3, 2013
in Cardiology, Infectious Disease
Reading Time: 2 mins read
Azithromycin is not associated with increased cardiovascular death in low-risk groups
Share on FacebookShare on Twitter

Image: PD

1. Use of azithromycin did not increase risk of cardiovascular death (CVD) in a general population of young and middle-aged adults. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The study finds that azithromycin is not associated with higher risk of cardiovascular death (CVD) in a general young and middle-aged population. In contrast, the Ray, et al study (see Relevant Reading) showed near 3-fold increase in CVD with azithromycin use in high risk patients. The message is one of risk stratification – azithromycin is safe for the general population with a low baseline risk of cardiovascular disease, while one must weigh benefits against potential risks in high-risk patients prone to cardiac dysrhythmias.

Click to read the study in NEJM

Relevant Reading: Azithromycin and the risk of cardiovascular death

RELATED REPORTS

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger

Azithromycin during routine well-infant visits does not reduce mortality

In-Depth [historical cohort study]: This study assessed the risk of death from cardiovascular causes associated with azithromycin use in a general population of young and middle-aged adults. The study compared rate of cardiovascular death (CVD) between the azithromycin group and no-use-of-antibiotics group, as well as between azithromycin and penicillin V groups.

The risk of CVD was significantly higher with current use (1 to 5 days, starting from the index date) of azithromycin compared to no use of antibiotics (rate ratio, RR, 2.85), this RR increases to 3.27 in sensitivity analysis (SA). Noncardiovascular death rate was also higher with current use of azithromycin (RR=1.60). In contrast, current use of azithromycin did not show a higher rate of CVD than penicillin V (RR=0.93 after adjusting for propensity scores; 95% CI, 0.56 to 1.55). This adjusted RR increased to 1.06 in SA.

The study concludes that azithromycin use is not associated with increased risk of CVD in a general young and middle-aged population.

By Xiaozhou Liu and Andrew Bishara

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: azithromycin
Previous Post

Patient satisfaction a poor surgical quality indicator

Next Post

School programs successfully cut number of smokers

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Infectious Disease

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

May 28, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger

September 30, 2024
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Azithromycin during routine well-infant visits does not reduce mortality

February 8, 2024
#VisualAbstract: Azithromycin during routine well-infant visits does not prevent death in Burkina Faso
StudyGraphics

#VisualAbstract: Azithromycin during routine well-infant visits does not prevent death in Burkina Faso

January 23, 2024
Next Post
School programs successfully cut number of smokers

School programs successfully cut number of smokers

Gestational weight loss may improve outcomes for obese women

Gestational weight loss may improve outcomes for obese women

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.